OPKO Health is a fully-integrated healthcare company focused on developing next-generation solutions for serious diseases. The company markets NGENLA (somatrogon, with Pfizer in 40+ countries) and RAYALDEE (calcifediol), operates BioReference Laboratories (one of the largest US clinical reference labs serving 11M patients/year), and conducts research into multispecific therapies for cancer and infectious disease.
growth hormone therapy, diagnostic laboratory services, multispecific therapeutic development, clinical reference laboratory, vitamin D therapeutics
2 sites worldwide
Involvement in 2 clinical trials
No reviews available yet.
No documents available.